Following guidance from a healthcare provider ensures safety
These symptoms may indicate a separate GI condition or medication intolerance requiring dose reduction or formulation change
While an individualized approach is necessary, further studies are required to understand how to effectively apply the combination approach and which cohort of people with obesity will benefit the most
Neuropharmacology 55, 345352
The right combination depends on your specific goals, health profile, and research priorities
Additionally, these agents suppress glucagon secretion from pancreatic alpha cells, slow gastric emptying, and promote satiety through central nervous system pathways, leading to reduced food intake and weight loss